All Pharma articles – Page 13
-
News
NMC: All graduate nurses should be ready to prescribe
Nurses could be able to prescribe medication “much sooner” in their careers than they currently can under plans being consulted on by the Nursing and Midwifery Council.
-
News
CCG and ICO probe pharmacy firm's access to patient details
A clinical commissioning group and the Information Commissioner are looking into concerns raised by a patient that a major online pharmacy has gained access to patients’ details to send out marketing material.
-
News
NHS England 'unethical' to propose withdrawing life changing drug
NHS England has been accused of being “totally unethical” after proposing to stop paying for a thyroid drug that is the “difference between living properly and not doing so” for patients.
-
News
'Dysfunctional' NHS England project damages UK reputation, say health tech firms
An organisation representing health technology firms has claimed a “dysfunctional” NHS England project is denying patients access to “life changing” treatment.
-
News
NHS England 'no option' but to hold back £120m from CCGs
“Urgent steps” have been taken to hold back funding intended for clinical commissioning groups, to help the Department of Health deliver financial balance this year.
-
News
NHS England defeated in court again over 'life changing' drug
A High Court judge has rebuked NHS England for denying a life changing drug to a seven year old boy in the face of “overwhelming” clinical evidence.
-
News
Pharma manager named as new DH chief commercial officer
The Department of Health has appointed a new chief commercial officer who will lead the renegotiation of pharmaceutical pricing regulation scheme.
-
Comment
The NHS is failing to keep up with the science
The NHS will be unable to provide new and advanced treatments unless policy makers take steps to mend its long term financial position, warns Harry Quilter-Pinner
-
News
Prescription changes would worsen health inequalities, warns BMA
The chair of the British Medical Association’s prescribing subcommittee has called for politicians to lead on changes to NHS prescriptions, which he claims could worsen health inequalities.
-
News
NHS England names 'ineffective' medicines for savings drive
NHS England is to consult over limiting the prescription of “low value” products costing £141m a year including homeopathy and herbal medicines.
-
Comment
Why strategic estates partnerships are a big thing
Trusts will increasingly turn to SEPs as they can help tighten purse strings and also evolve standards of care, writes Richard Coe
-
News
Extra £86m to fund NHS technology and innovation
The government has announced an extra £86m to boost uptake of technology and innovation in the NHS, including £35m to be paid directly to small and medium sized enterprises.
-
Expert Briefing
The Commissioner: 'Difficult choices' run out of steam
What NHS England isn’t telling you, and more indispensable weekly insight for commissioners, by Dave West.
-
News
CQC criticises 'unsafe' digital GP service
The Care Quality Commission has uncovered unsafe prescribing practises at another digital health provider, including a doctor prescribing sleeping disorder drug to keep a person awake for work.
-
News
Former DH chief to lead alliance to stand up for NHS in Brexit talks
Former DH permanent secretary Sir Hugh Taylor to co-chair Brexit Health Alliance with NHS Confederation chief executive Niall Dickson Alliance will aim to safeguard NHS interests as the UK government negotiates Brexit Calls for the government to make commitments on research and funding An alliance of healthcare industry, ...
-
News
Second court defeat for NHS England
NHS England faces judicial review over decision not to fund drug for 7-year-old boy Lawyers will argue NHSE should have considered the boy’s welfare under the Children Act Victory could create a new duty on NHS England when making commissioning decisions affecting children Lawyers have been granted permission ...
-
News
Exclusive: NICE to routinely review drugs' budget impact for NHS England
NICE asked by NHS England to analyse the “finance impact” of new potential treatments Second programme in which a NICE review of treatment costs could potentially impact access NICE will grade clinical evidence available for each treatment, which may impact rare disease medicines The National Institute for Health ...
-
News
New alliance to fight NHS's corner during Brexit talks
Alliance of NHS organisations to speak up for the health service to be announced within the month NHS Confederation behind the plan, which will not argue for or against Brexit The group will aim to ensure issues affecting NHS are recognised by government An alliance of NHS organisations ...
-
Comment
We must act as England falls behind on access to rare disease medicines
It is crucial that we develop a bespoke process to evaluate ‘orphan’ medicines if we are to eradicate inequality in the system, says Sebastian Stachowiak
-
News
Trust and royal college raise concerns over drug savings drive
Drug used for pain management in palliative and cancer care included in NHS England list of drugs up for review The Christie medical director says NHS would be doing a “disservice” to patients if it withdrew use of fentanyl Royal college specialist raises concerns the review will lead to ...